Urologic Diseases  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
NCT00170053: Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids

Completed
1
177
US
Sirolimus
Mayo Clinic, Wyeth is now a wholly owned subsidiary of Pfizer, Genzyme, a Sanofi Company, Raymond Heilman
Kidney Diseases
09/08
09/08
RESTARRT, NCT01318915: Research Study of ATG and Rituximab in Renal Transplantation

Terminated
1
10
US
ATG, Thymoglobulin, Antithymocyte globulin, Rituximab, Rituxan, Tacrolimus, Prograf, FK-506, Fujimycin, Sirolimus, Rapamune, Rapamycin, MMF, mycophenolate mofetil
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Renal Transplant Recipients
06/16
08/17

Download Options